• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖药物治疗时代的间歇性禁食与心血管风险展望

A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy.

作者信息

Eliopoulos Aristides G, Gkouskou Kalliopi K, Tsioufis Konstantinos, Sanoudou Despina

机构信息

Department of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Center for New Biotechnologies and Precision Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Front Nutr. 2025 Jan 17;12:1524125. doi: 10.3389/fnut.2025.1524125. eCollection 2025.

DOI:10.3389/fnut.2025.1524125
PMID:39895836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11782017/
Abstract

Intermittent fasting has been linked to metabolic health by improving lipid profiles, reducing body weight, and increasing insulin sensitivity. However, several randomized clinical trials have shown that intermittent fasting is not more effective than standard daily caloric restriction for short-term weight loss or cardiometabolic improvements in patients with obesity. Observational studies also suggest cardiovascular benefits from extended rather than reduced eating windows, and indicate that long-term intermittent fasting regimens may increase the risk of cardiovascular disease mortality. In this perspective, we discuss evidence that may support potential adverse effects of intermittent fasting on cardiovascular health through the loss of lean mass, circadian misalignment and poor dietary choices associated with reward-based eating. Given the ongoing revolution in obesity pharmacotherapy, we argue that future research should integrate anti-obesity medications with dietary strategies that confer robust benefits to cardiometabolic health, combine exercise regimens, and consider genetic factors to personalize obesity treatment. Comprehensive approaches combining diet, pharmacotherapy, and lifestyle modifications will become crucial for managing obesity and minimizing long-term cardiovascular risk.

摘要

间歇性禁食已通过改善血脂水平、减轻体重和提高胰岛素敏感性与代谢健康联系起来。然而,几项随机临床试验表明,对于肥胖患者的短期体重减轻或心脏代谢改善,间歇性禁食并不比标准的每日热量限制更有效。观察性研究还表明,延长进食窗口而非缩短进食窗口对心血管有益,并指出长期间歇性禁食方案可能会增加心血管疾病死亡风险。从这个角度来看,我们讨论了一些证据,这些证据可能支持间歇性禁食通过瘦体重减少、昼夜节律失调以及与基于奖励的饮食相关的不良饮食选择对心血管健康产生潜在不利影响。鉴于肥胖药物治疗正在进行的变革,我们认为未来的研究应将抗肥胖药物与对心脏代谢健康有显著益处的饮食策略相结合,结合运动方案,并考虑遗传因素以实现肥胖治疗的个性化。将饮食、药物治疗和生活方式改变相结合的综合方法对于管理肥胖和将长期心血管风险降至最低至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6bb/11782017/8a244dde2498/fnut-12-1524125-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6bb/11782017/8a244dde2498/fnut-12-1524125-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6bb/11782017/8a244dde2498/fnut-12-1524125-g001.jpg

相似文献

1
A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy.肥胖药物治疗时代的间歇性禁食与心血管风险展望
Front Nutr. 2025 Jan 17;12:1524125. doi: 10.3389/fnut.2025.1524125. eCollection 2025.
2
Intermittent fasting interventions for the treatment of overweight and obesity in adults aged 18 years and over: a systematic review protocol.间歇性禁食干预治疗18岁及以上成年人超重和肥胖:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):60-8. doi: 10.11124/jbisrir-2015-2363.
3
Fasting for weight loss: an effective strategy or latest dieting trend?禁食以减肥:是一种有效策略还是最新的节食潮流?
Int J Obes (Lond). 2015 May;39(5):727-33. doi: 10.1038/ijo.2014.214. Epub 2014 Dec 26.
4
Intermittent fasting for the prevention of cardiovascular disease.间歇性禁食预防心血管疾病。
Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013496. doi: 10.1002/14651858.CD013496.pub2.
5
Comparison of weight loss induced by daily caloric restriction versus intermittent fasting (DRIFT) in individuals with obesity: study protocol for a 52-week randomized clinical trial.每日热量限制与间歇性禁食(DRIFT)对肥胖个体减肥效果的比较:一项为期 52 周的随机临床试验研究方案。
Trials. 2022 Aug 29;23(1):718. doi: 10.1186/s13063-022-06523-2.
6
Intermittent fasting and time-restricted eating role in dietary interventions and precision nutrition.间歇性禁食和限时进食在饮食干预和精准营养中的作用。
Front Public Health. 2022 Oct 28;10:1017254. doi: 10.3389/fpubh.2022.1017254. eCollection 2022.
7
The Effects of Isocaloric Intermittent Fasting vs Daily Caloric Restriction on Weight Loss and Metabolic Risk Factors for Noncommunicable Chronic Diseases: A Systematic Review of Randomized Controlled or Comparative Trials.等热量间歇性禁食与每日热量限制对非传染性慢性疾病体重减轻和代谢风险因素的影响:随机对照或比较试验的系统评价。
J Acad Nutr Diet. 2023 Feb;123(2):318-329.e1. doi: 10.1016/j.jand.2022.09.013. Epub 2022 Sep 17.
8
Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis.间歇性禁食干预治疗成人超重和肥胖:一项系统评价和荟萃分析。
JBI Database System Rev Implement Rep. 2018 Feb;16(2):507-547. doi: 10.11124/JBISRIR-2016-003248.
9
Intermittent fasting as a nutrition approach against obesity and metabolic disease.间歇性禁食作为一种对抗肥胖和代谢性疾病的营养方法。
Curr Opin Clin Nutr Metab Care. 2020 Nov;23(6):387-394. doi: 10.1097/MCO.0000000000000694.
10
A Narrative Review of Intermittent Fasting With Exercise.运动与间歇性禁食的叙述性综述
J Acad Nutr Diet. 2025 Feb;125(2):153-171. doi: 10.1016/j.jand.2024.05.015. Epub 2024 Jun 1.

引用本文的文献

1
Mitochondria: the hidden engines of traumatic brain injury-driven neurodegeneration.线粒体:创伤性脑损伤所致神经退行性变的隐匿引擎
Front Cell Neurosci. 2025 May 9;19:1570596. doi: 10.3389/fncel.2025.1570596. eCollection 2025.

本文引用的文献

1
Intermittent fasting influences immunity and metabolism.间歇性禁食影响免疫和代谢。
Trends Endocrinol Metab. 2024 Sep;35(9):821-833. doi: 10.1016/j.tem.2024.04.014. Epub 2024 May 8.
2
Association between variants in , , and genes and response to therapy with glucagon-like peptide-1 receptor agonists.基因 、 、 变体与胰高血糖素样肽-1 受体激动剂治疗反应的相关性。
Postgrad Med. 2024 Mar;136(2):218-225. doi: 10.1080/00325481.2024.2328513. Epub 2024 Mar 11.
3
Physical activity in metabolic syndrome.代谢综合征中的身体活动
Front Physiol. 2024 Feb 19;15:1365761. doi: 10.3389/fphys.2024.1365761. eCollection 2024.
4
A genomics perspective of personalized prevention and management of obesity.从基因组学角度看肥胖的个性化预防和管理
Hum Genomics. 2024 Jan 29;18(1):4. doi: 10.1186/s40246-024-00570-3.
5
Effect of Calorie Restriction and Intermittent Fasting Regimens on Brain-Derived Neurotrophic Factor Levels and Cognitive Function in Humans: A Systematic Review.热量限制和间歇性禁食方案对人类脑源性神经营养因子水平和认知功能的影响:一项系统评价
Medicina (Kaunas). 2024 Jan 22;60(1):191. doi: 10.3390/medicina60010191.
6
Time of eating and mortality in U.S. adults with heart failure: Analyses of the National Health and Nutrition Examination Survey 2003-2018.美国心力衰竭成年患者的进食时间与死亡率:2003 - 2018年美国国家健康与营养检查调查分析
Nutr Metab Cardiovasc Dis. 2024 Feb;34(2):445-454. doi: 10.1016/j.numecd.2023.10.013. Epub 2023 Oct 14.
7
Dietary circadian rhythms and cardiovascular disease risk in the prospective NutriNet-Santé cohort.膳食昼夜节律与前瞻性 NutriNet-Santé 队列中的心血管疾病风险。
Nat Commun. 2023 Dec 14;14(1):7899. doi: 10.1038/s41467-023-43444-3.
8
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.司美格鲁肽在肥胖但无糖尿病患者中的心血管结局。
N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11.
9
Clinical effectiveness of semaglutide on weight loss, body composition, and muscle strength in Chinese adults.在中国成年人中,司美格鲁肽在体重减轻、身体成分和肌肉力量方面的临床效果。
Eur Rev Med Pharmacol Sci. 2023 Oct;27(20):9908-9915. doi: 10.26355/eurrev_202310_34169.
10
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.超重或肥胖成年人强化生活方式干预后使用替尔泊肽:SURMOUNT-3 期临床试验。
Nat Med. 2023 Nov;29(11):2909-2918. doi: 10.1038/s41591-023-02597-w. Epub 2023 Oct 15.